Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -82.84%-3.56M | -117.30%-946.28K | -19.63%-412.58K | -18.29%-3.7M | 27.56%-970.42K | -91.51%-1.95M | -29.02%-435.47K | 20.17%-344.89K | 35.23%-3.13M | 27.92%-1.34M |
| Net income from continuing operations | -184.96%-4.49M | -131.56%-1.5M | 54.75%-374.53K | -6.76%-3.63M | 46.96%-584.82K | 0.70%-1.57M | -112.50%-647.33K | -101.12%-827.74K | 44.08%-3.4M | 39.54%-1.1M |
| Operating gains losses | -258.02%-4.6K | 56,913.33%8.55K | 400.00%150 | --9.46K | --6.5K | 59.77%2.91K | 100.86%15 | 109.84%30 | ---- | ---- |
| Depreciation and amortization | ---9.11K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 32.60%6.67K | 9,084.80%858.14K | --0 | 25.25%34.42K | --2.08K | --5.03K | -15.01%9.34K | 8.98%17.97K | -97.14%27.48K | --0 |
| Other non cashItems | ---- | ---- | ---- | 239.59%163.16K | -289.63%-107.52K | 174.96%3.07K | -2.45%-3.85K | 33,990.51%271.46K | -49.03%48.05K | --56.7K |
| Change In working capital | 344.99%936.38K | -252.25%-314.17K | -119.75%-38.2K | -232.06%-269.14K | 2.48%-286.67K | -166.82%-382.22K | 637.65%206.36K | 639.60%193.39K | -1.27%203.81K | -101.69%-293.95K |
| -Change in receivables | 402.96%5.84K | -122.42%-2.39K | -535.40%-8.35K | 167.31%8.05K | -82.10%-2.6K | 43.29%-1.93K | 435.26%10.67K | 148.51%1.92K | -110.59%-11.97K | -26.33%-1.43K |
| -Change in prepaid assets | 750.36%64.72K | -14,724.67%-280.04K | -670.25%-56.05K | -250.79%-43.86K | -826.57%-41.84K | 56.83%-9.95K | -121.04%-1.89K | -79.38%9.83K | -90.78%29.08K | -101.40%-4.52K |
| -Change in payables and accrued expense | 333.79%865.82K | -116.06%-31.74K | -85.57%26.21K | -224.99%-233.34K | 15.90%-242.22K | -161.88%-370.34K | 547.22%197.58K | 328.32%181.64K | 280.68%186.69K | 38.22%-288.01K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -82.84%-3.56M | -117.30%-946.28K | -19.63%-412.58K | -18.29%-3.7M | 27.56%-970.42K | -91.51%-1.95M | -29.02%-435.47K | 20.17%-344.89K | 35.23%-3.13M | 27.92%-1.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -53.28%-89.11K | -194.54K | 42.84K | -16.20%-71.3K | -82.87%-13.16K | -58.13K | 0 | 0 | 23.46%-61.36K | -7.2K |
| Net PPE purchase and sale | ---88.37K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---735 | ---145.44K | --42.84K | -16.20%-71.3K | -82.87%-13.16K | ---- | ---- | ---- | 23.46%-61.36K | ---7.2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -53.28%-89.11K | ---194.54K | --42.84K | -16.20%-71.3K | -82.87%-13.16K | ---58.13K | --0 | --0 | 23.46%-61.36K | ---7.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -104.22%-7.12K | 8.45M | -4.17%2.91M | 0 | 2.74M | 168.75K | 0 | -45.66%3.04M | -104.97%-682 |
| Net common stock issuance | --0 | -104.22%-7.12K | --8.45M | -4.17%2.91M | --0 | -9.74%2.74M | --168.75K | --0 | -45.02%3.04M | -102.65%-682 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---18.68K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -104.22%-7.12K | --8.45M | -4.17%2.91M | --0 | --2.74M | --168.75K | --0 | -45.66%3.04M | -104.97%-682 |
| Net cash flow | ||||||||||
| Beginning cash position | 1,520.79%7.13M | 1,071.52%8.28M | -81.25%197.19K | -12.22%1.05M | -50.78%1.18M | -87.32%439.98K | -7.73%706.69K | -12.22%1.05M | 135.35%1.2M | -21.15%2.4M |
| Current changes in cash | -592.32%-3.65M | -330.40%-1.15M | 2,443.34%8.08M | -483.86%-854.39K | 27.00%-983.58K | 169.22%740.8K | -109.87%-266.72K | 20.17%-344.89K | -121.24%-146.34K | 26.96%-1.35M |
| End cash Position | 195.06%3.48M | 1,520.79%7.13M | 1,071.52%8.28M | -81.25%197.19K | -81.25%197.19K | -50.78%1.18M | -87.32%439.98K | -7.73%706.69K | -12.22%1.05M | -12.22%1.05M |
| Free cash from | -87.38%-3.65M | -128.58%-995.39K | -19.63%-412.58K | -18.29%-3.7M | 27.56%-970.42K | -91.51%-1.95M | -29.02%-435.47K | 20.17%-344.89K | 35.23%-3.13M | 27.92%-1.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.